UC Davis Researcher Receives the "Translation from Clinical Use into Public Benefit and Policy Award" from the ACTS

Diana Miglioretti, dean’s professor and division chief of biostatistics in the department of Public Health Sciences, has won the prestigious Distinguished Investigator Award from the Association of Clinical and Translational Science (ACTS).

Dr. Diana Miglioretti recognized for her research on breast cancer screening. The UC Davis School of Medicine nominated Miglioretti for the Distinguished Investigator Award under the “Translation into Public Benefit and Policy” category. This category recognizes achievement in applying translational research findings into effective public policies that promote health or implementation and dissemination of translational solutions.

“I am thrilled and honored to receive this award,” Miglioretti said. “This award acknowledges the importance and impact of the research I am conducting with my colleagues in the Breast Cancer Surveillance Consortium to develop more effective breast cancer screening strategies.”

As one of only 3 faculty awards presented this year, Fred Meyers, outgoing ACTS President, expressed his appreciation. "On behalf of the Association of Clinical and Translational Science and with my own personal congratulations, I am pleased to celebrate with you and your colleagues your award as the 2020 recipient of the Translation from Clinical Use into Public Benefit and Policy Award," said Meyers.

The UC Davis CTSC provided bridge funding to help Dr. Miglioretti continue her project between funding phases.

Publishing CTSA Program Hub’s Name